Correct classification of death causes is an important component of transplant trials.We aimed to develop and validate a system to classify causes of death in hematopoietic stem cell (HSCT) and solid organ (SOT) transplant recipients.Case record forms (CRF) of fatal cases were completed, including investigator-designated cause of death. Deaths occurring in 2010 to 2013 were used for derivation; and were validated by deaths occurring in 2013 to 2015. Underlying cause of death (referred to as recorded underlying cause) was determined through a central adjudication process involving 2 external reviewers, and subsequently compared with the Danish National Death Cause Registry.Three hundred eighty-eight recipients died 2010 to 2015 (196 [51%] SO...
Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for certain hematol...
BACKGROUND: Donation after circulatory death (DCD) is a procedure in which after planned withdrawal ...
BACKGROUND: Organ shortage remains a problem in transplantation. An expansion of the donor pool coul...
Correct classification of death causes is an important component of transplant trials.We aimed to de...
AbstractClinical trials commonly use adjudication committees to refine endpoints, but observational ...
Monitoring specific underlying causes of death in solid organ transplant (SOT) recipients is importa...
Background: Post heart-transplant survival has increased, but information is lacking on specific cau...
AbstractThe primary cause of death (COD) provides important information in many studies of hematopoi...
Information on incidence, and factors associated with mortality is a prerequisite to improve outcome...
AbstractAutopsy is the gold standard for establishing the cause of death. We present results of the ...
BACKGROUND: Relapse and transplant-related complications are leading causes of mortality after hemat...
<p>(<b>A</b>) Patient-and-graft survival ( = overall graft survival) : patient deaths with a functio...
Aim: The aim of this study is to investigate the clinical features of graft dysfunction following li...
Hematopoietic cell transplantation (HCT) is potentially curative for patients with hematologic disor...
A patient undergoing hematopoietic stem cell transplant faces various risk factors and has become th...
Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for certain hematol...
BACKGROUND: Donation after circulatory death (DCD) is a procedure in which after planned withdrawal ...
BACKGROUND: Organ shortage remains a problem in transplantation. An expansion of the donor pool coul...
Correct classification of death causes is an important component of transplant trials.We aimed to de...
AbstractClinical trials commonly use adjudication committees to refine endpoints, but observational ...
Monitoring specific underlying causes of death in solid organ transplant (SOT) recipients is importa...
Background: Post heart-transplant survival has increased, but information is lacking on specific cau...
AbstractThe primary cause of death (COD) provides important information in many studies of hematopoi...
Information on incidence, and factors associated with mortality is a prerequisite to improve outcome...
AbstractAutopsy is the gold standard for establishing the cause of death. We present results of the ...
BACKGROUND: Relapse and transplant-related complications are leading causes of mortality after hemat...
<p>(<b>A</b>) Patient-and-graft survival ( = overall graft survival) : patient deaths with a functio...
Aim: The aim of this study is to investigate the clinical features of graft dysfunction following li...
Hematopoietic cell transplantation (HCT) is potentially curative for patients with hematologic disor...
A patient undergoing hematopoietic stem cell transplant faces various risk factors and has become th...
Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for certain hematol...
BACKGROUND: Donation after circulatory death (DCD) is a procedure in which after planned withdrawal ...
BACKGROUND: Organ shortage remains a problem in transplantation. An expansion of the donor pool coul...